共 50 条
- [21] Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderlyANNALS OF ONCOLOGY, 2011, 22 (09) : 2080 - 2085Fritsch, K.Kasenda, B.Hader, C.Nikkhah, G.Prinz, M.Haug, V.Haug, S.Ihorst, G.Finke, J.Illerhaus, G.
- [22] Intrathecal treatment with liposomal cytarabine combined with systemic chemotherapy in elderly patients with primary CNS lymphoma (PCNSL)ONKOLOGIE, 2010, 33 : 47 - 47Kowoll, A.Pels, H.Reiser, M.Engert, A.Herrlinger, U.Lamprecht, M.Egerer, G.Vogt-Schaden, M.Hau, P.Schackert, G.Reichmann, H.Kroschinsky, F.Schlegel, U.Schmidt-Wolf, I
- [23] Phase II trial of recurrent primary CNS lymphoma (PCNSL) treated with pemetrexedJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Altman, J. K.Tellez, C.Chandler, J.Levy, R. M.Getch, C.Cohn, R.Gallot, L.Marymont, M.Grimm, S. A.Raizer, J. J.
- [24] Single institution retrospective review of patients with primary CNS lymphoma (PCNSL).JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Johnson, Andrew ThomasNooruddin, ZohraKing, Gentry TengSchade, Henning HelmutKamdar, Manali K.Haverkos, Brad M.Ney, Douglas Edward
- [25] G-PCNSL-SG-1 randomized phase III trial of high-dose methotrexate with or without whole brain radiotherapy for primary central nervous system lymphoma: Long-term follow-up.JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Korfel, AgnieszkaThiel, EckhardMartus, PeterMoehle, RobertGriesinger, FrankRauch, MichaelRoeth, AlexanderHertenstein, BerndFischer, ThomasHundsberger, ThomasMergenthaler, Hans-GuentherJunghanss, ChristianBirnbaum, TobiasFischer, LarsJahnke, KristophHerrlinger, UlrichPlasswilm, LudwigNaegele, ThomasPietsch, TorstenWeller, Michael
- [26] Toxicity of high-dose methotrexate (HDMTX) based chemotherapy in primary CNS lymphoma (PCNSL): preliminary experience from a randomized phase III study (G-PCNSL-SG1, NCT00153530)EJC SUPPLEMENTS, 2009, 7 (02): : 561 - 561Korfel, A.Weller, M.Martus, P.Thiel, E.
- [27] Thiel et al. High-dose methotrexate with or without whole brain radiation therapy for primary CNS lymphoma (G-PCNSL-SG-1): A phase 3, randomized, non-inferiority trial. Lancet Oncol 2010. (15)International Journal of Radiation Oncology Biology Physics, 2014, 90 (04): : 722 - 723Gibbs, Iris C.Shoo, B. Aika
- [28] First Results of the Acse Pembrolizumab Phase II in the Primary CNS Lymphoma (PCNSL) CohortBLOOD, 2020, 136Hoang-Xuan, KheHouot, RochSoussain, CaroleBlonski, MarieSchmitt, AnnaDelwail, VincentDamaj, Gandhi LaurentGhesquieres, HervePeyrade, FredericTempescul, AdrianAbraham, JulieAgape, PhilippeAhle, GuidoBaize, NathalieBories, PierreCampello, ChantalGyan, EmmanuelJardin, FabriceRey, PhilippeChoquet, SylvainHouillier, CarolineCassoux, NathalieTouitou, ValerieMartin-Duverneuil, NadineLegrand, FredericLamrani-Ghaouti, AssiaQuerel, OphelieLabouret, Natalie HoogSimon, ClotildeChevret, SylvieMassard, Christophe
- [29] IMMUNOCHEMOTHERAPY WITH RITUXIMAB AND METHOTOREXATE WITH DEFERRED RADIOTHERAPY FOR NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA (PCNSL) IN THE ELDERLYNEURO-ONCOLOGY, 2013, 15 : 121 - 121Mishima, KazuhikoAdachi, Jun-ichSuzuki, TomonariUchida, EitaYanagawa, TaroWatanabe, YukoFukuoka, KoheiYanagisawa, TakaakiWakiya, KenjiFujimaki, TakamitsuNishikawa, Ryo
- [30] Visual loss from radiation retinopathy in primary CNS lymphoma (PCNSL) survivorsNEUROLOGY, 2005, 64 (06) : A18 - A18Grimm, SADeAngelis, LMAbrey, LE